Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors

SIMPLE SUMMARY: Lung cancer is the leading cause of cancer-related death worldwide. Nonsmall cell lung cancer (NSCLC) accounts for 80–85% of all cases. Immune checkpoint inhibitors (ICIs) have revolutionized the field of oncology by improving survival in cancer patients. However, given their limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudura, Ken, Ritz, Nando, Kutzker, Tim, Hoffmann, Martin H. K., Templeton, Arnoud J., Foerster, Robert, Kreissl, Michael C., Antwi, Kwadwo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776660/
https://www.ncbi.nlm.nih.gov/pubmed/36551581
http://dx.doi.org/10.3390/cancers14246095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776660/
https://www.ncbi.nlm.nih.gov/pubmed/36551581
http://dx.doi.org/10.3390/cancers14246095

Ejemplares similares